| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.965 | 143 | 11 | 1991 | 2019 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
disease | 0.050 | None | 0.800 | 5 | 7 | 2008 | 2014 | ||||||||
|
XPC complex subunit, DNA damage recognition and repair factor | 0.504 | 0.808 | 3.7E-11 |
|
disease | 0.020 | None | 1.000 | 2 | 6 | 2015 | 2018 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 5 | 2009 | 2010 | ||||||||
|
serine protease 1 | 0.563 | 0.692 | 4.1E-11 |
|
disease | 0.100 | None | 0.900 | 20 | 4 | 1997 | 2019 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.100 | None | 0.818 | 11 | 4 | 2002 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.983 | 242 | 3 | 1985 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.980 | 102 | 3 | 1995 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.100 | None | 1.000 | 18 | 3 | 2004 | 2019 | ||||||||
|
nuclear receptor subfamily 5 group A member 2 | 0.563 | 0.731 | 0.24 |
|
disease | 0.200 | None | 1.000 | 10 | 3 | 2010 | 2018 | ||||||||
|
HOX transcript antisense RNA | 0.475 | 0.769 |
|
disease | 0.080 | None | 1.000 | 8 | 3 | 2013 | 2019 | |||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
disease | 0.040 | None | 1.000 | 4 | 3 | 2009 | 2010 | |||||||||
|
somatostatin receptor 5 | 0.590 | 0.615 | 9.6E-04 |
|
disease | 0.040 | None | 1.000 | 4 | 3 | 2004 | 2015 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 3 | 2014 | 2019 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 3 | 2006 | 2012 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 3 | 2017 | 2019 | |||||||||
|
cytochrome P450 family 24 subfamily A member 1 | 0.518 | 0.692 | 3.2E-23 |
|
disease | 0.020 | None | 1.000 | 2 | 3 | 2013 | 2015 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 0.986 | 70 | 2 | 2003 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 60 | 2 | 2003 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 1.000 | 55 | 2 | 2003 | 2020 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
disease | 0.100 | None | 1.000 | 42 | 2 | 1994 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.100 | None | 1.000 | 19 | 2 | 2011 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.100 | None | 1.000 | 18 | 2 | 1985 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.100 | None | 1.000 | 17 | 2 | 2004 | 2020 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.100 | None | 1.000 | 12 | 2 | 2000 | 2015 |